Free Essay

Neuroendocrine Systems and Postpartum Depression

In:

Submitted By lilly7
Words 959
Pages 4
Having a baby should be one of the happiest and most important events in a woman’s life. However, it can also be a difficult and quite stressful task. Many physical and emotional changes can occur to a woman during the time of her pregnancy as well as following the birth of her child. These particular changes can leave a new mother feeling sad, anxious, afraid and confused. For many women, these feelings, which are known as baby blues, go away fairly quickly. But when they do not go away or rather they get worse, a woman may be experiencing the effects of postpartum depression (PPD). Abrupt hormone withdrawal is the most obvious change in immediate postpartum, but clues to the mood disturbance may lie in the deregulation of neuroendocrine systems, including how hormones affect neurotransmitters and their actions within the brain.
The baby blues are common for numerous reasons. The baby’s crying and the mother’s interrupted sleep and breast-feeding are enough to make any woman feel irritable if not overwhelmed. The onset of postpartum depression, on the other hand, is believed to be caused by chemical imbalances in the brain; specifically shifts in hormone levels. According to postpartum Support International (PSI), the theory to date suggests that a sharp drop in estrogen and progesterone following delivery is the culprit.1
Ovarian steroids play an important regulatory role in a women’s general sense of wellbeing. Studies have found significant positive correlations between the onset of PPD and postpartum withdrawal of estrogen and progesterone levels.2
Aside from estrogen’s many roles in our developmental health, it is also known to be a neuro-stimulant with anti-depressive effects. High levels of estrogen produce an imbalance in the system that aggravates symptoms of anxiety. On the other hand, low levels of estrogen can lead to episodes of depression.3
A deficiency of progesterone is also a factor in postpartum depression. When estrogen levels are high and progesterone levels low, patients would exhibit extreme rage followed by self-defeating behavior. This is not surprising because the largest concentration of progesterone receptors is in the limbic area of the brain, which is the center of emotion; also called the “area of rage and violence”.3
Both estrogen and progesterone hormones have been found to alter dopamine activity. "Without estrogen, more than 30 percent of all the dopamine neurons disappeared in a major area of the brain that produces the neurotransmitter, dopamine, " said D. Eugene Redmond, Jr., professor of psychiatry and neurosurgery at Yale School of Medicine and director of the Neural Transplantation and Regeneration Program. Dopamine plays an important role in regulating our drive to seek out rewards, as well as our ability to obtain a sense of pleasure. Low dopamine levels may in part explain why depressed people don’t derive the same sense of pleasure out of activities.4
Another hormone that could trigger postpartum depression is the corticotropin-releasing hormone (CRH). Several lines of evidence suggest the possibility that increased CRH may be a risk factor for PPD. When we are under stress, the hypothalamus secretes CRH, which increases the amount of Cortisol in the blood. Cortisol raises blood sugar levels and maintains normal blood pressure, which helps us perform well under stress. During the last trimester of pregnancy, the placenta secretes so much CRH into the blood that the levels increase threefold. When CRH levels are high, the hypothalamus releases less CRH. The sudden disappearance of the placenta after delivery results in a sharp drop of CRH levels. It takes a while for the hypothalamus to get the signal that it needs to start making more CRH again. It has been suggested that this may explain the occurrence of postpartum depressive disorders.5
Postnatal depression is also believed to be caused by a deficiency of neurotransmitters specifically serotonin and norepinephrine. These neurotransmitters are fundamental to health because they transmit nerve impulses throughout the nervous system, and have a profound effect on mood and self-esteem.
Serotonin is a neurotransmitter produced in the brain and is often referred to as the ‘feel good’ hormone. What happens during pregnancy is that the exchange between the blood of mother and fetus is courtesy of the placenta regulating levels of serotonin. After birth, when the fetus and placenta are gone, blood continues flowing from the mother’s uterine until platelets move in to stop it. Serotonin levels begin to rise and interact with receptors on the smooth muscle of the uterus. This stimulates the production of interleukin-1 beta (a protein), which creates more serotonin transporters on the neurons when they are not needed. Until interleukin-1 beta levels normalize, there is too little communication between serotonergic neurons leading to postpartum depression.6
In addition, the brain synthesizes serotonin and dopamine in line with levels of norepinephrine. Our adrenal glands are responsible for producing the stress hormones of norepinephrine. During pregnancy, the changes in the balance of hormones can cause exhaustion to the adrenal gland, which in turn affects norepinephrine and serotonin productions simultaneously.
Another line of research has investigated linkage between stress, depression, and norepinephrine. Norepinephrine helps our body to recognize and respond to stressful situations. Researchers suggest that people who are vulnerable to depression may have a system that doesn’t handle the effects of stress very effectively.7
Postpartum depression may be affected by many factors, including our social and physical environment, diet, and daily sleep patterns, just to name a few. But the reality is that those same factors affect our hormones, which regulate our brain’s response system. Steroid hormones, especially estrogens and progesterone, are the most powerful chemical signals affecting the brain. Changes in the levels of these ovarian hormones influence neurotransmitters such as dopamine and serotonin, which affect moods.

Similar Documents

Premium Essay

About Depression (Not Mine)

...(State of the art Basic concepts of depression Eugene S. Paykel, MD, FRCP, FRCPsych, FMedSci Historical background This paper reviews concepts of depression, including history and classification. The original broad concept of melancholia included all forms of quiet insanity. The term depression began to appear in the nineteenth century, as did the modern concept of affective disorders, with the core disturbance now viewed as one of mood. The 1980s saw the introduction of defined criteria into official diagnostic schemes. The modern separation into unipolar and bipolar disorder was introduced following empirical research by Angst and Perris in the 1960s. The partially overlapping distinctions between psychotic and neurotic depression, and between endogenous and reactive depression, started to generate debate in the 1920s, with considerable multivariate research in the 1960s. The symptom element in endogenous depression currently survives in melancholia or somatic syndrome. Life stress is common in various depressive pictures. Dysthymia, a valuable diagnosis, represents a form of what was regarded earlier as neurotic depression. Other subtypes are also discussed. © 2008, LLS SAS rior to the late 19th century, although detailed systems of classification abounded, the main problem for psychiatric nosology was the establishment of the broad major disorders. Melancholia was recognized as early as the time of Hippocrates, and continued through Galenic medicine and medieval...

Words: 8469 - Pages: 34

Free Essay

Psychiatry

... 333 malingering, 530–531 ‘manic depressive insanity’, 45 manic states, 250, 253 abnormal beliefs and perceptions, 254 amphetamines and, 266 course and outcome, 274 delusional, 16 in HIV patients, 345 in ICD-10, 42 in old age aetiology, 369 clinical features, 370 treatment, 370 in old age, 369–370 mixed state with depression, 255 sensations in, 6 stroke and, 344 stupor in, 31 manic states, 15–17 Marchiafava-Bignami syndrome, 206, 338 Marijuana Anonymous, 239 marital status, and suicide, 454 masculinity drunkenness and, 428 sense of, 395 Massachusetts Male Aging Study, 402 Massachusetts Women’s Health Study (MWHS), 442 masturbation, 396 McNaughton Rules, 558 McNaughton, Daniel, 558 m-CPP 435 , MDMA (3, 4-methylenedioxymethamphetamine; ‘ecstasy’), 328 medial temporal lobe volume in Alzheimer’s disease, 359 MRI for detecting, 75 medical conditions anxiety disorders in, 170 depression treatment, 521 detection of psychiatric illness, 483 feigned illness, 530–531 mental disorders due to, 327 anxiety disorders, 333 cannabis and psychosis, 330 catatonia, 332 cognitive disorders, 334 delusions, 329 depression and Parkinson’s disease, 332 general principles, 327 hallucinations, 328 mood disorders, 330 personality disorder, 333 psychotic disorder, 328 stimulant psychosis, 329 mental disorders due to, 326–335 relationship to affective change, 270 suicide risk and, 455 medically unexplained symptoms, 523 biological mechanisms, 526 ...

Words: 7400 - Pages: 30

Premium Essay

International Classification of Diseases Coding Ii

...International Classification of Diseases Coding II Chapter 17 – 27 Chapter 17: 1. Which of the following anemias is caused by a failure of the bone marrow to produce red blood cells and may be congenital or acquired? A. Bone marrow deficiency anemia B. Sickle-cell anemia C. Aplastic anemia D. Thalassemia 2. Which of the following terms refers to either a reduction in the quantity of hemoglobin or a reduction in the volume of red blood cells? E. Anemia F. Coagulation defect G. Thrombocytopenia H. Leukocytosis 3. When a diagnostic statement of anemia is not qualified in any way, what should the coder do? I. Review the record for a surgical procedure; and if the patient had surgery, code as anemia due to acute blood loss. J. Review the medical record before assigning an unspecified type of anemia. K. Review the medical record to determine if the patient has been prescribed iron tablets, and code as iron-deficiency anemia. L. Review the medical record to determine if the patient has received chemotherapy, and assign the code for anemia due to antineoplastic chemotherapy. 4. Which of the following statements is true regarding a patient with documented sickle-cell trait? M. The patient has sickle-cell disease. N. Both of the patient’s parents carried the sickle-cell gene. O. The code for sickle-cell disease should be assigned. P. The patient received...

Words: 10050 - Pages: 41

Free Essay

Nclex

...A kid with Hepatitis A can return to school 1 week within the onset of jaundice. 2. After a patient has dialysis they may have a slight fever...this is normal due to the fact that the dialysis solution is warmed by the machine. 3. Hyperkalemia presents on an EKG as tall peaked T-waves 4. The antidote for Mag Sulfate toxicity is ---Calcium Gluconate 5. Impetigo is a CONTAGEOUS skin disorder and the person needs to wash ALL linens and dishes seperate from the family. They also need to wash their hands frequently and avoid contact. positive sweat test. indicative of cystic fibrosis 1. Herbs: Black Cohosh is used to treat menopausal symptoms. When taken with an antihypertensive, it may cause hypotension. Licorice can increase potassium loss and may cause dig toxicity. 2. With acute appendicitis, expect to see pain first then nausea and vomiting. With gastroenitis, you will see nausea and vomiting first then pain. 3. If a patient is allergic to latex, they should avoid apricots, cherries, grapes, kiwi, passion fruit, bananas, avocados, chestnuts, tomatoes and peaches. 4. Do not elevate the stump after an AKA after the first 24 hours, as this may cause flexion contracture. 5. Beta Blockers and ACEI are less effective in African Americans than Caucasians. 1. for the myelogram postop positions. water based dye (lighter) bed elevated. oil based dye heavier bed flat. 2.autonomic dysreflexia- elevated bed first....then check foley...

Words: 72133 - Pages: 289

Premium Essay

Mental Health Ati

...PN MENTAL HEALTH NURSING EDITION . CO NT ASTERY SERI ES TM N E R EV MOD IE W LE U PN Mental Health Nursing Review Module Edition 9.0 CONtriButOrs Sheryl Sommer, PhD, RN, CNE VP Nursing Education & Strategy Janean Johnson, MSN, RN Nursing Education Strategist Sherry L. Roper, PhD, RN Nursing Education Strategist Karin Roberts, PhD, MSN, RN, CNE Nursing Education Coordinator Mendy G. McMichael, DNP, RN Nursing Education Specialist and Content Project Coordinator Marsha S. Barlow, MSN, RN Nursing Education Specialist Norma Jean Henry, MSN/Ed, RN Nursing Education Specialist eDitOrial aND PuBlisHiNg Derek Prater Spring Lenox Michelle Renner Mandy Tallmadge Kelly Von Lunen CONsultaNts Deb Johnson-Schuh, RN, MSN, CNE Loraine White, RN, BSN, MA PN MeNtal HealtH NursiNg i PN MeNtal HealtH NursiNg review Module editioN 9.0 intellectual Property Notice ATI Nursing is a division of Assessment Technologies Institute®, LLC Copyright © 2014 Assessment Technologies Institute, LLC. All rights reserved. The reproduction of this work in any electronic, mechanical or other means, now known or hereafter invented, is forbidden without the written permission of Assessment Technologies Institute, LLC. All of the content in this publication, including, for example, the cover, all of the page headers, images, illustrations, graphics, and text, are subject to trademark, service mark, trade dress, copyright, and/or other intellectual property rights or licenses...

Words: 83801 - Pages: 336

Free Essay

Documents

...Clinical guidelines Diagnosis and treatment manual for curative programmes in hospitals and dispensaries guidance for prescribing 2010 EDITION © Médecins Sans Frontières – January 2010 All rights reserved for all countries. No reproduction, translation and adaptation may be done without the prior permission of the Copyright owner. ISBN 2-906498-81-5 Clinical guidelines Diagnosis and treatment manual Editorial Committee: I. Broek (MD), N. Harris (MD), M. Henkens (MD), H. Mekaoui (MD), P.P. Palma (MD), E. Szumilin (MD) and V. Grouzard (N, general editor) Contributors: P. Albajar (MD), S. Balkan (MD), P. Barel (MD), E. Baron (MD), M. Biot (MD), F. Boillot (S), L. Bonte (L), M.C. Bottineau (MD), M.E. Burny (N), M. Cereceda (MD), F. Charles (MD), M.J de Chazelles (MD), D. Chédorge (N), A.S. Coutin (MD), C. Danet (MD), B. Dehaye (S), K. Dilworth (MD), F. Fermon (N), B. Graz (MD), B. Guyard-Boileau (MD), G. Hanquet (MD), G. Harczi (N), M. van Herp (MD), C. Hook (MD), K. de Jong (P), S. Lagrange (MD), X. Lassalle (AA), D. Laureillard (MD), M. Lekkerkerker (MD), J. Maritoux (Ph), J. Menschik (MD), D. Mesia (MD), A. Minetti (MD), R. Murphy (MD), J. Pinel (Ph), J. Rigal (MD), M. de Smet (MD), S. Seyfert (MD), F. Varaine (MD), B. Vasset (MD) (S) Surgeon, (L) Laboratory technician, (MD) Medical Doctor, (N) Nurse, (AA) Anaesthetist-assistant, (Ph) Pharmacist, (P) Psychologist We would like to thank the following doctors for their invaluable help:...

Words: 86687 - Pages: 347